Here are seven key notes:
1. Greatbatch will pay $478 million in cash and 5.1 million in shares.
2. The deal is valued at $1.73 billion, including the assumption of debt.
3. The combined company will have about $1.5 billion in revenues.
4. Both companies’ boards have approved the deal.
5. Lake Region Medical develops cardio and vascular products as well as advances surgical products, which includes spine and joint reconstruction devices.
6. Synergies from the deal are expected to be about $25 million in 2016 and are estimated to increase to $60 million in 2018.
7. The acquisition is the latest in a string of medical device company mergers in 2015. The Zimmer-Biomet merger closed in June, and Medtronic completed its acquisition of Covidien in January.
More articles on devices:
1st surgeries with the Conventus PH Cage in the US & Europe are complete — 5 observations
Xtant Medical to present at Rodman Renshaw global investment conference: 4 notes
Providence Medical reaches $12M in new financing for DTRAX products, appoints new leadership: 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
